Analyzing Ardelyx Inc (ARDX)’s financial ratios for investment purposes

As of close of business last night, Ardelyx Inc’s stock clocked out at $7.41, up 1.51% from its previous closing price of $7.30. In other words, the price has increased by $+0.11 from its previous closing price. On the day, 5418481 shares were traded.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Ratios:

To gain a deeper understanding of ARDX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.64 and its Current Ratio is at 4.88. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.31.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on December 18, 2023, initiated with a Strong Buy rating and assigned the stock a target price of $12.

On September 07, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $9.

Cantor Fitzgerald Upgraded its Neutral to Overweight on August 25, 2023, whereas the target price for the stock was revised from $5 to $10.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 20 ’24 when GRAMMER ELIZABETH A sold 86,000 shares for $7.73 per share. The transaction valued at 664,978 led to the insider holds 312,993 shares of the business.

Rosenbaum David P. sold 5,183 shares of ARDX for $47,684 on Feb 26 ’24. The Chief Development Officer now owns 175,936 shares after completing the transaction at $9.20 per share. On Feb 20 ’24, another insider, RAAB MICHAEL, who serves as the President & CEO of the company, sold 22,917 shares for $8.75 each. As a result, the insider received 200,439 and left with 1,319,951 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 1.72B and an Enterprise Value of 1.59B. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.85 while its Price-to-Book (P/B) ratio in mrq is 10.33. Its current Enterprise Value per Revenue stands at 12.80 whereas that against EBITDA is -28.79.

Stock Price History:

Over the past 52 weeks, ARDX has reached a high of $10.13, while it has fallen to a 52-week low of $3.16. The 50-Day Moving Average of the stock is 8.72, while the 200-Day Moving Average is calculated to be 5.49.

Shares Statistics:

It appears that ARDX traded 6.33M shares on average per day over the past three months and 5.78M shares per day over the past ten days. A total of 232.45M shares are outstanding, with a floating share count of 223.69M. Insiders hold about 3.87% of the company’s shares, while institutions hold 59.56% stake in the company. Shares short for ARDX as of Mar 15, 2024 were 36.31M with a Short Ratio of 5.74, compared to 30.06M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 15.60% and a Short% of Float of 15.87%.

Earnings Estimates

As of right now, 8 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.11 and a low estimate of -$0.23, while EPS last year was -$0.13. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.08 and low estimates of -$0.19.

Analysts are recommending an EPS of between -$0.2 and -$0.76 for the fiscal current year, implying an average EPS of -$0.45. EPS for the following year is $0, with 7 analysts recommending between $0.4 and -$0.44.

Revenue Estimates

In the current quarter, 8 analysts expect revenue to total $36.71M. It ranges from a high estimate of $40M to a low estimate of $30.5M. As of the current estimate, Ardelyx Inc’s year-ago sales were $11.37M, an estimated increase of 222.90% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $47.8M, an increase of 213.00% less than the figure of $222.90% in the same quarter last year. There is a high estimate of $52.67M for the next quarter, whereas the lowest estimate is $41.63M.

A total of 8 analysts have provided revenue estimates for ARDX’s current fiscal year. The highest revenue estimate was $232.22M, while the lowest revenue estimate was $181.9M, resulting in an average revenue estimate of $209.51M. In the same quarter a year ago, actual revenue was $124.46M, up 68.30% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $357.72M in the next fiscal year. The high estimate is $425.74M and the low estimate is $288.6M. The average revenue growth estimate for next year is up 70.70% from the average revenue estimate for this year.

Most Popular